Skip to content
Menu

Adaptimmune Therapeutics plc ADAPY

Full chart Compare
Set alert

Price alert · ADAPY

All alert types
0.03 USD +0.01 (+27.66%)

As ofNov 19, 2026, 3:50 PM EST

0.029 Day range 0.0325
0.001 52-week range 0.07
YTD
+15.38%
1 year
-50.82%

ADAPY free cash flow history

Free cash flow is operating cash flow minus capital expenditure outflow. It can be negative; it is not the same as earnings.

-74,092,000 USD

FY 2024 · Period ended

Coverage: stale. Values in USD; not inflation adjusted.

Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.

Capital expenditure here is net of asset disposals, so free cash flow can be higher than a figure that subtracts gross purchases.

Scroll the table to see all values →

Free cash flow · annual · USD
Fiscal periodPeriod endFree cash flowYoY changeYoY %
FY 20242024-12-31-74,092,00071,469,000Not meaningful
FY 20232023-12-31-145,561,00025,704,000Not meaningful
FY 20222022-12-31-171,265,000-173,420,000-8047.33%
FY 20212021-12-312,155,00058,087,000Not meaningful
FY 20202020-12-31-55,932,00058,167,000Not meaningful
FY 20192019-12-31-114,099,000-5,801,000Not meaningful
FY 20182018-12-31-108,298,000-29,890,000Not meaningful
FY 20172017-12-31-78,408,000-18,734,000Not meaningful
FY 20162016-12-31-59,674,000Not availableNot available
FY 20152015-06-30-34,624,000-70,093,000-197.62%
FY 20142014-06-3035,469,000Not availableNot available

Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.

Company-reported financial statements. Retrieved 2025-10-31T11:55:19.000Z. Retrieval time is not a report date.

Open full statements

Use Add to watchlist above to save this stock.